Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • investor1989I Offline
    investor1989I Offline
    investor1989
    wrote on sidst redigeret af
    #985

    Novod har en EPS på 65 i 2020 for Genmab. x30 i P/E og kursen er 1950 dvs. ca. 2000

    1 Reply Last reply
    0
    • DarvinD Offline
      DarvinD Offline
      Darvin
      wrote on sidst redigeret af
      #986

      Hvilket bør være laveste bud - vis der kommer bud i 2015. Også såfremt budgiver kun går efter Dara

      1 Reply Last reply
      0
      • DarvinD Offline
        DarvinD Offline
        Darvin
        wrote on sidst redigeret af
        #987

        hvis

        1 Reply Last reply
        0
        • investor1989I Offline
          investor1989I Offline
          investor1989
          wrote on sidst redigeret af
          #988

          Og husk Jan præsenterer hos GS i morgen

          1 Reply Last reply
          0
          • I Offline
            I Offline
            ienk1
            wrote on sidst redigeret af
            #989

            hvad har GS som kursmål

            1 Reply Last reply
            0
            • investor1989I Offline
              investor1989I Offline
              investor1989
              wrote on sidst redigeret af
              #990

              pas

              1 Reply Last reply
              0
              • I Offline
                I Offline
                ienk1
                wrote on sidst redigeret af
                #991

                Jeg mener at kunne huske , at de lå meget lavt

                1 Reply Last reply
                0
                • FantomasF Offline
                  FantomasF Offline
                  Fantomas
                  wrote on sidst redigeret af
                  #992

                  http://investor.borsen.dk/artikel/1/298223/danske_loefter_genmab-kursmaal_markant.html kan ikke lige huske om de har opdateret kursmålet siden.

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    Goose3
                    wrote on sidst redigeret af
                    #993

                    FF hæver til 715 (fra 620)

                    1 Reply Last reply
                    0
                    • investor1989I Offline
                      investor1989I Offline
                      investor1989
                      wrote on sidst redigeret af
                      #994

                      Han er ved at blive lidt sød ham Frank 😄

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        Goose3
                        wrote on sidst redigeret af
                        #995

                        Jeps men altid farligt med FF. Kan huske at jeg undlod af sælge Neuroseach da han blev ved med at sige at data var gode nok til en ansøgning. Det var de så ikke!

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          Goose3
                          wrote on sidst redigeret af
                          #996

                          Så jeg lytter ikke til FF mere selvom alle kan tage fejl!

                          1 Reply Last reply
                          0
                          • 1 Offline
                            1 Offline
                            120281
                            wrote on sidst redigeret af
                            #997

                            @i89: Kan du sende mig en PB kan ikke lige finde det. Ang. aktiebrev.

                            1 Reply Last reply
                            0
                            • DarvinD Offline
                              DarvinD Offline
                              Darvin
                              wrote on sidst redigeret af
                              #998

                              Resumeet fra ASCO har jo været fremme siden 30 maj - men havde ikke selv set denne tilføjelse ( Medscape), det har i måske, men her er den: "A response lasting 7.4 months in this population is quite remarkable," commented Suzanne Lentzsch, MD, PhD, director of the Multiple Myeloma and Amyloidosis Service at New York–Presbyterian Hospital/Columbia University Medical Center, in New York City. "This shows its potency in a heavily pretreated population."

                              "This is a study of 106 patients, which is

                              1 Reply Last reply
                              0
                              • DarvinD Offline
                                DarvinD Offline
                                Darvin
                                wrote on sidst redigeret af
                                #999

                                "This is a study of 106 patients, which is fairly large and straightforward and gives us insight into the single-drug activity with this agent," said Dr Lentzsch, who was approached by Medscape Medical News for independent commentary.

                                However, Dr Lentzsch believes that daratumumab will probably not be used as a single agent but as part of combination therapy. Daratumumab is currently being studied in several ongoing phase 3 trials that are exploring daratumumab in combination with various exist

                                1 Reply Last reply
                                0
                                • DarvinD Offline
                                  DarvinD Offline
                                  Darvin
                                  wrote on sidst redigeret af
                                  #1000

                                  However, Dr Lentzsch believes that daratumumab will probably not be used as a single agent but as part of combination therapy. Daratumumab is currently being studied in several ongoing phase 3 trials that are exploring daratumumab in combination with various existing regimens in different stages of the disease.

                                  "The next step is to establish efficacy in combination with other agents and to bring it to frontline therapy," she said.

                                  1 Reply Last reply
                                  0
                                  • DarvinD Offline
                                    DarvinD Offline
                                    Darvin
                                    wrote on sidst redigeret af
                                    #1001

                                    Undskyld det mindre overlap mellem det tastede

                                    1 Reply Last reply
                                    0
                                    • DarvinD Offline
                                      DarvinD Offline
                                      Darvin
                                      wrote on sidst redigeret af
                                      #1002

                                      Bemærk at det er en uafhængig kommentar der bedes om !

                                      1 Reply Last reply
                                      0
                                      • DarvinD Offline
                                        DarvinD Offline
                                        Darvin
                                        wrote on sidst redigeret af
                                        #1003

                                        Hun er ikke en hvem som helst

                                        1 Reply Last reply
                                        0
                                        • celsiusC Offline
                                          celsiusC Offline
                                          celsius
                                          wrote on sidst redigeret af
                                          #1004

                                          også mangler du bare at beskrive din konklusion med nedenstående, jeg er ikke helt med på hvorfor du linker det -:)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger